Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 616 AL 630

Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease

Tan SH, Karri V, Tay NWR, Chang KH, Ah HY, Ng PQ, Ho HS, Keh HW, Candasamy M.

Biomed Pharmacother. 2019 Mar;111:765-777. doi: 10.1016/j.biopha.2018.12.101. Epub 2019 Jan 3.

Accuracy of Transcranial Sonography of the Substantia Nigra for Detection of Parkinson's Disease: A Systematic Review and Meta-analysis

Tao A, Chen G, Deng Y, Xu R.

Ultrasound Med Biol. 2019 Mar;45(3):628-641. doi: 10.1016/j.ultrasmedbio.2018.11.010. Epub 2019 Jan 3.

The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system

Heiss CN, Olofsson LE.

J Neuroendocrinol. 2019 May;31(5):e12684. doi: 10.1111/jne.12684. Epub 2019 Feb 1.

Effects of robot-assisted gait training in patients with Parkinson's disease: study protocol for a randomized controlled trial

Kang MG, Yun SJ, Shin HI, Kim E, Lee HH, Oh BM, Seo HG.

Trials. 2019 Jan 7;20(1):15. doi: 10.1186/s13063-018-3123-4.

Malignant syndrome triggered by influenza A virus infection in a patient with Parkinson's disease with improvement after intravenous peramivir treatment

Matsuzono K, Baba M, Imai G, Imai H, Fujimoto S.

Neurol Sci. 2019 Jun;40(6):1291-1294. doi: 10.1007/s10072-018-3696-4. Epub 2019 Jan 7.

Therapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2

Bahn G, Jo DG.

Neuromolecular Med. 2019 Mar;21(1):1-11. doi: 10.1007/s12017-018-08523-5. Epub 2019 Jan 7.

Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases

Gureev AP, Popov VN.

Neurochem Res. 2019 Oct;44(10):2273-2279. doi: 10.1007/s11064-018-02711-2. Epub 2019 Jan 7.

Atypical parkinsonism with severely reduced striatal dopamine uptake associated with a 16p11.2 duplication syndrome

Roeben B, Blum D, Gabriel H, Synofzik M.

J Neurol. 2019 Mar;266(3):775-776. doi: 10.1007/s00415-019-09182-7. Epub 2019 Jan 7.

Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells

Stoddard-Bennett T, Reijo Pera R.

Cells. 2019 Jan 7;8(1):26. doi: 10.3390/cells8010026.

The Role of Lipids in Parkinson's Disease

Xicoy H, Wieringa B, Martens GJM.

Cells. 2019 Jan 7;8(1):27. doi: 10.3390/cells8010027.

Vibrational Approach to the Dynamics and Structure of Protein Amyloids

Li H, Lantz R, Du D.

Molecules. 2019 Jan 6;24(1):186. doi: 10.3390/molecules24010186.

The "great" controlling nucleotide coenzymes

Veech RL, Todd King M, Pawlosky R, Kashiwaya Y, Bradshaw PC, Curtis W.

IUBMB Life. 2019 May;71(5):565-579. doi: 10.1002/iub.1997. Epub 2019 Jan 9.

Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial

Solla P, Cugusi L, Bertoli M, Cereatti A, Della Croce U, Pani D, Fadda L, Cannas A, Marrosu F, Defazio G, Mercuro G.

J Altern Complement Med. 2019 Mar;25(3):305-316. doi: 10.1089/acm.2018.0413. Epub 2019 Jan 9.

The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease

Liss B, Striessnig J.

Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:263-289. doi: 10.1146/annurev-pharmtox-010818-021214.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias